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Abstract
Background: The robustness of epidemiological research using routinely collected primary care electronic data
to support policy and practice for common mental disorders (CMD) anxiety and depression would be greatly
enhanced by appropriate validation of diagnostic codes and algorithms for data extraction. We aimed to create
a robust research platform for CMD using population-based, routinely collected primary care electronic data.
Methods: We developed a set of Read code lists (diagnosis, symptoms, treatments) for the identification of anxiety
and depression in the General Practice Database (GPD) within the Secure Anonymised Information Linkage Databank
at Swansea University, and assessed 12 algorithms for Read codes to define cases according to various criteria. Annual
incidence rates were calculated per 1000 person years at risk (PYAR) to assess recording practice for these CMD
between January 1st 2000 and December 31st 2009. We anonymously linked the 2799 MHI-5 Caerphilly Health
and Social Needs Survey (CHSNS) respondents aged 18 to 74 years to their routinely collected GP data in SAIL.
We estimated the sensitivity, specificity and positive predictive value of the various algorithms using the MHI-5
as the gold standard.
Results: The incidence of combined depression/anxiety diagnoses remained stable over the ten-year period in
a population of over 500,000 but symptoms increased from 6.5 to 20.7 per 1000 PYAR. A ‘historical’ GP diagnosis
for depression/anxiety currently treated plus a current diagnosis (treated or untreated) resulted in a specificity of
0.96, sensitivity 0.29 and PPV 0.76. Adding current symptom codes improved sensitivity (0.32) with a marginal
effect on specificity (0.95) and PPV (0.74).
Conclusions: We have developed an algorithm with a high specificity and PPV of detecting cases of anxiety
and depression from routine GP data that incorporates symptom codes to reflect GP coding behaviour. We have
demonstrated that using diagnosis and current treatment alone to identify cases for depression and anxiety using
routinely collected primary care data will miss a number of true cases given changes in GP recording behaviour.
The Read code lists plus the developed algorithms will be applicable to other routinely collected primary care
datasets, creating a platform for future e-cohort research into these conditions.
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Background
Common mental disorders (CMD) are an important pub-
lic health problem comprising depression, anxiety, panic
and somatisation and usually presenting as mixed
syndromes with mixed symptoms. They are significant
contributors to impaired health, well-being and health ser-
vices utilisation, direct and indirect costs to the economy
and overall mortality [1–4] CMD have a combined com-
munity prevalence of between 15 % and 30 %, depending
on the population and case definition used [5, 6].
The community prevalence of CMD is significantly
greater than in primary are because only around one-third
of affected people seek help in primary care [7]. Among at-
tendees, depression and anxiety (the most common CMDs)
often go unrecognised [7–11]. Ten years ago, of those
recognised, fewer than one-third received treatment [12].
Up to three-quarters may have visited their physician in
the previous year with seemingly unrelated complaints
[13–16]. In primary care settings, decisions about who
should receive treatment for recognised CMD seem to be
made on a patient-by-patient basis, influenced by the sever-
ity of symptoms demonstrated [17]. In the UK over the last
decade, GPs have become more likely to record individual
symptoms rather than specific CMD diagnoses [18, 19].
Routinely collected electronic health records have the
potential to support policy and enhance the practice of
health and social care. The validity and reliability of re-
search using routinely collected primary care electronic
data depends upon its quality and completeness. Overall,
the validity of primary care diagnoses in the UK tends to
be high, although the quality of reporting and detailed
descriptions of validation methods are often variable and
inadequate [20].
Any method clarifying the most robust way to iden-
tify a case of anxiety and depression from routinely col-
lected primary care data would support research in this
area. Previously we identified suitable participants for a
trial in depression using electronic general practice data
by an internal validation methodology involving two
independent clinicians [21]. In this study we assess our
ability to identify cases of CMD in the primary care
dataset by an external validation method using a survey
administered mental health score.
Methods
Aim
We aimed to create a robust research platform for CMD
(anxiety and depression) using population-based, routinely
collected primary care electronic data.
Objectives
We planned to create Read code lists and algorithms to
identify primary care recorded CMD anxiety and depres-
sion in order to assess any changes in diagnostic recording
for CMD anxiety and depression in the General Practice
Dataset (GPD) between January 1st 2000 and December
31st 2009 in those aged over 18 years. These algorithms
for case-finding of primary care recorded anxiety and
depression will then be compared to the five-item Mental
Health Inventory (MHI-5), as a measure of mental health
status.
Ethical approval
The ethical considerations of this project were cov-
ered by permissions granted to the Swansea Secure
Anonymised Information Linkage (SAIL) Databank and
the Caerphilly Health and Social Needs Survey (CHSNS)
[22]. Additionally we gained approval from the Swansea
University Information Governance Review Panel, an
independent body consisting of a range of government,
regulatory and professional agencies, including the NHS
Research Ethics Service and members of the public, which
grants approval to studies conducted within the SAIL
Databank.
Data source
Caerphilly health & social needs survey
The CHSNS is a community study of health inequality set
in Caerphilly county borough, Wales [22–24]. The current
dataset comprises a two-wave cross-sectional postal
questionnaire survey. The baseline survey sample (wave 1)
was drawn from a total population of 132,613 residents
aged 18 years and over recorded in the then current local
General Medical Practice administrative register on May
31st 2001. This produced a representative dataset on
10,892 residents of the borough, aged 18 to 74 years. The
response rate for wave 1 was 63.0 %. In 2008, a follow-up
postal questionnaire survey was carried out (wave 2) of
surviving baseline respondents, then aged 25 to 81 years,
with a response rate of 50.2 % [23, 24].
Measure of mental health
Both waves of the survey included responses to SF-36, ver-
sion 2, health status questionnaire. The measure of mental
health in this study was the five-item MHI-5, a sub-scale
of the SF-36. Its validity and reliability, as a measure of
mental health status, are well established [25, 26] and
reflect the continuously distributed, single dimensional
nature of CMD symptoms in the population [27, 28]. We
restricted this analysis to those aged under 75 years at
baseline, the MHI-5 being less reliable in UK elderly
populations [29, 30]. The assessment of CMD using the
MHI-5 scale has been performed previously and is well
established [22, 31–34]. It performs at least as well as the
General Health Questionnaire [22, 31–36]. The response
scores were transformed using the scale developers’
published method, with imputation of missing data, to a
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scale of range 0 to 100, with lower scores indicating
poorer mental health [37].
Our previous work [38] has demonstrated a range of
methods for producing a cut-point on the MHI-5 thus
overcoming earlier limitations [31, 39]. We state that
investigators should consider carefully the cut-point
most suitable for their study based primarily on the
intended application of the resulting cut-point. We chose
a cut-point of ≤60 on the MHI-5 to minimise misclassifi-
cation rate since we were interested in the within-borough
comparisons between MHI-5 scores and GP diagnoses.
SAIL Databank
The SAIL databank is the national data repository of anon-
ymised, person-based, linkable data in Wales covering a
population of 3 million [40, 41]. Robust policies, structures
and controls are in place to protect privacy through a reli-
able matching, anonymisation and encryption process
achieved in conjunction with the NHS Wales Informatics
Service (NWIS) using a split file approach as detailed by
Ford et al. (2009) and Lyons et al., (2009). The split file
approach involves separation of identifiers from clinical
content, identity matching and creation of pseudonymised
linkage keys (Anonymised Linking Fields) by NWIS prior
to reassembling and further encryption of data sets using
different algorithms within the University (Fig. 1).
The primary care dataset in SAIL (GPD) contains Read
codes for each registered individual in a SAIL supplying
practice. Read codes are a hierarchical nomenclature
used to record clinical summary information. Primary
care physicians enter medical diagnoses and symptoms
using Read codes. The GPD does not contain any ac-
companying free text on referral or discharge to or from
secondary/tertiary care. It is regularly updated.
E-cohort creation
The survey dataset was imported into the SAIL databank
and an electronic cohort created by record-linking the
baseline survey data demographics to the primary care
dataset using the Welsh Demographic Service (WDS)
dataset in NWIS. WDS contains the unique NHS number
for all individuals who register with the free to use general
medical practitioner service (Fig. 1).
Primary care case selection
Read code lists, corresponding to ICD-10 Chapter V [42]
diagnoses of anxiety and depression, were developed by
clinical members of the study team with reference to Rait
et al. [18] and the Quality Outcomes Framework [43]
(Additional file 1: Table S1). These included GP recording
of i) anxiety diagnoses e.g. generalized anxiety disorder; ii)
anxiety symptoms e.g. anxiousness; iii) mixed anxiety and
depression; iv) panic attacks and panic disorders; v) depres-
sion diagnoses; vi) depression symptoms. We excluded
codes for other psychosis, phobias, obsessive compulsive
disorders, post traumatic stress disorder, behavioural
disorders, hyperkinetic disorders, conduct disorders and
disorders of social functioning in keeping with other stud-
ies of this type [18, 19]. We excluded adjustment disorders
as conceptually they are an intermediate health condition
between normal responses to stress and more severe
emotional disorders such as anxiety and depression [44].
We also compiled a Read code list of British National
Formulary listed antidepressants, anxiolytics and hypnotics
[45] (Additional file 2: Table S2).
We queried the GPD using db2 structured query lan-
guage, implementing Read Codes Version 2 (5-byte set).
We used, devised algorithms and evaluated multiple
methods to define a case of anxiety and depression (12 in
total as listed in Table 2) incorporating, in various combi-
nations, current and historical diagnoses, symptoms and
treatments. Our definition of ‘current’ was a search for
relevant Read codes over a one-year period with the date
of the survey response at the midpoint. This was in order
to capture those who may present to their GP with CMD
but not be diagnosed for a period of time and also those
who may delay seeing their GPs for a period of time. Our
definition of ‘historical’ was a search for relevant Read
codes through the retrospective longitudinal data housed
in the GPD outside the ‘current’ period. The length of
Fig. 1 Split file approach to linking survey data to primary care data
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retrospective data varied between individuals depending
on the length of their registration with a SAIL supplying
practice and was longer for wave 2 respondents. Treat-
ment was at least one prescription for an antidepressant,
anxiolytic or hypnotic in the one-year current period.
Statistical analysis
The data were analysed using SPSS Statistics software
(Version 20). We calculated a ten-year period prevalence
of anxiety and depression diagnosis in the GPD popula-
tion between January 1st 2000 and December 31st 2009 in
those aged over 18 years using the study Read code lists.
We calculated annual incidence rates of recorded anxiety
and depression, based on diagnoses, symptoms and diag-
noses and symptoms combined, between 2000 and 2010
to assess changes in diagnostic recording practice for the
inclusion of certain codes in our study. A new episode was
defined as an entry in the records with no previous entry
of that problem recorded in the previous year. We
therefore reviewed data from January 1st 1999.
Annual incidence rates were calculated per 1000 per-
son years at risk (PYAR). We calculated person-time at
risk using the start of each year (1st January) or start of
registration (plus 6 months) whichever was the later for
each of the years. The end date was the earliest of the
following: date of leaving a SAIL supplying practice, date
of death or the end of the target year (31st December).
We excluded the first six months of data following
registration. This allowed for retrospective recording to
reduce the chance of prevalent cases being recorded as
incident. It was a requirement that each individual
contributed at least one year’s follow-up data.
We then compared the ‘primary care cases’, for each of
the 12 definitions, to the ‘survey cases’ separately for
both waves of the survey. Sensitivity, specificity and
positive predictive values (PPV) for the 12 defined
algorithms were calculated, using a cut-point of ≤60 for
the MHI-5 (as gold standard) [38]. Sensitivity measures
the proportion of cases and specificity the proportion of
non-cases, identified in the survey data, correctly identi-
fied as such in primary care. The PPV is the probability
that the person identified by the algorithm is a survey
case and is expressed as a proportion.
We explored the reasons for algorithm 9, based on
diagnosis and treatment codes only, identifying false
negatives and false positive cases (including the role of
symptom codes in this) in the Wave 2 sample since
these are the codes used in current literature.
Results
Identification of READ codes corresponding to anxiety
and depression diagnosis in the SAIL databank GPD
Five hundred twenty two thousand and five hundred
seventy eight patients were registered continuously with
a GP within the SAIL databank from 1st January 2000 to
31st December 2009. The ten-year period prevalence of
GP recorded diagnoses of anxiety and depression during
this time was 16.2 % (n = 84,835). Where individuals had
more than one type of diagnosis, the ten-year period
prevalence for depressive disorders was 9.3 % (n = 48,382),
mixed anxiety and depression 4.8 % (n = 25,256), and anx-
iety disorders 6.4 % (n = 33,284). If depression and anxiety
symptom codes were included, the ten-year prevalence
was 21.4 % (n = 111,768).
GPs’ electronic recording of depression and anxiety
Table 1 and Fig. 2 show trends in the incidence of de-
pression and anxiety between 1st January 2000 and 31st
December 2009. The incidence of recorded depression
and anxiety diagnoses (combined) remained stable over
the ten-year period but the incidence of recorded
symptoms increased substantially from 6.5 to 20.7 per
1000 PYAR. The combined incidence of diagnoses and
symptoms of depression and anxiety increased from 24.4
to 34.9 1000 PYAR.
Study population
There were 691,762 individuals aged 18–74 (38.5 % of
relevant population in Wales) registered to a SAIL supply-
ing practice continuously between 1st May 2001 and 30th
April 2002 (wave 1 period) and 805,929 (44.8 % of relevant
population in Wales) individuals aged 18–74 registered
continuously to a SAIL supplying practice between 1st
May 2008 and 30th April 2009 (wave 2 period).
The CHSNS dataset included 10,653 MHI-5 scores from
wave 1 and 4,426 MHI-5 scores from wave 2. We matched
2,584 of 10,653 (24.3 %) wave 1 survey responders and
1,195 of 4,426 (27.0 %) wave 2 responders, corresponding
to 2799 individuals with MHI-5 scores, to their primary
care data. This was on the basis of continuous registration
Table 1 Incidence of GP recorded depression/anxiety broken
down by diagnoses and symptoms in the SAIL databank
2000–2010 per 1000 person-years at risk (PYAR)
Year Diagnosis recorded
(Depression & Anxiety)
Symptom recorded
(Depression & Anxiety)
Either Diagnosis
or symptom
recorded
2000 20.3 6.5 24.4
2001 23.1 6.8 27.3
2002 25.3 9.6 31.2
2003 26.0 12.7 34.0
2004 25.5 16.6 36.7
2005 24.7 17.9 37.0
2006 26.1 20.3 39.7
2007 21.6 20.1 35.6
2008 20.4 19.0 33.8
2009 20.0 20.7 34.9
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with a SAIL supplying practice for the 12-month period at
the time of the survey response. Among these, 824 (32 %)
had scores of ≤60 on the MHI-5 at Wave 1 and 395
(33 %) at Wave 2.
There were 84 (3.3 %) CHSNS MHI-5 responders in
wave 1 and 54 (4.5 %) in wave 2 linked in SAIL with a
current diagnosis or symptom of anxiety and depression
in the GPD. There were 198 (7.7 %) responders in wave
1 and 188 (15.7 %) in wave 2 linked in SAIL with a his-
torical diagnosis or symptom of anxiety or depression
currently treated in GPD.
Validation results
Table 2 shows the sensitivity, specificity and PPV for the
comparison of GP Read codes for anxiety and depression
diagnoses, symptoms and treatment with MHI-5 data
from the CHSNS waves using a cut-point of ≤60. As ex-
pected, all the algorithms underestimated the prevalence
of CMD compared to the MHI-5, particularly those based
only on current diagnosis or symptoms. The addition of
historical diagnoses with current treatment contributed
most to increasing the sensitivity.
False positives
Based on algorithm 9 (historical diagnosis currently treated
plus current diagnosis treated or untreated) using wave 2
data we incorrectly identified 36 of 800 patients (4.5 %) as a
case of CMD in SAIL, all of whom had at least one
historical code for a diagnosis of depression and/or anxiety
(Table 3). Of these, 35 (97.2 %) were being currently
treated.
False negatives
A total of 280 of 395 (70.9 %) survey cases were not
identified using this algorithm (Table 3). Of these, 76
(27.1 %) were currently being treated but had no
diagnostic Read codes for anxiety or depression recorded
in their GP records. However, 25 (8.9 %) individuals did
have current symptom codes, and 32 (11.4 %) had his-
torical diagnosis codes (17 of whom had a historical
symptom code), but were not being currently treated
and nine (3.2 %) were registered with a practice but had
no record of any attendances with their GP during that
one-year period.
The majority of false negatives 200/280 (71 %) had a
historical recording of pain and 139/280 (50 %) had one
of the following chronic physical diseases–cardiovascular
disease, diabetes, digestive disorder, kidney disorder,
thyroid problem, chronic migraines, chronic obstructive
pulmonary disease or one of the top seven cancers (as
defined by World Health Organisation). Thirty-nine of
the 280 (14 %) subjects had CMD other than depression
and anxiety such as stress or other neurotic disorders.
Alcohol dependency accounted for 6.8 % (19/280). Other
mental health related disorders such as psychotic
disorders and drug dependencies were present; however,
they accounted for a very small number.
Discussion
Main findings
We have created a set of algorithms to identify cases of
CMD anxiety and depression from routinely collected
GP data. We linked survey data containing a validated
instrument (MHI-5) for CMD to the GP record and
compared results with recorded anxiety and depression
diagnoses, symptoms and treatment codes to assess the
sensitivity, specificity and PPV of the group of codes and
algorithms chosen.
We then calculated the ten-year period prevalence and
incidence of anxiety and depression diagnosis in a large
primary care population. The recorded incidence of
combined anxiety and depression diagnoses in Wales
Fig. 2 Trends in the incidence of GP recorded anxiety and depression (2000–2010)
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Table 2 Sensitivity, specificity, positive predictive value-results comparing GP Read codes for anxiety and depression diagnoses, symptoms and treatment with MHI-5 data (as the gold
standard) from the CHSNS waves
Algorithm: CMD diagnosis/symptom/treatment Wave (W) True Positivesa True negativesb Sensitivity Specificity Positive Predictive
value
Number of cases identified by algorithm
n (prevalence, %)–includes false positives
W1, n= 2584 W2, n= 1195
1. Current treatment only W1 268 1590 0.33 0.90 0.61 438 (17.0)
W2 189 712 0.48 0.89 0.68 277 (23.2)
2. Current diagnosis (treated or untreated) W1 50 1737 0.06 0.99 0.68 73 (2.8)
W2 20 792 0.05 0.99 0.71 28 (2.3)
3. Current diagnosis treated W1 48 1742 0.06 0.99 0.73 66 (2.6)
W2 18 793 0.05 0.99 0.72 25 (2.1)
4. Current diagnosis or symptom (treated or untreated) W1 57 1733 0.07 0.99 0.68 84 (3.3)
W2 37 783 0.09 0.98 0.69 54 (4.5)
5. Current diagnosis or symptom (treated only) W1 53 1738 0.06 0.99 0.71 75 (2.9)
W2 32 785 0.08 0.98 0.68 47 (3.9)
6. Current treatment plus untreated current diagnosis or symptom W1 272 1585 0.33 0.90 0.61 447 (17.3)
W2 194 710 0.49 0.89 0.68 284 (23.8)
7. Historical or current diagnosis currently treated W1 121 1697 0.15 0.96 0.66 184 (7.1)
W2 113 765 0.29 0.96 0.76 148 (12.4)
8. Historical or current diagnosis or symptom currently treated W1 131 1693 0.16 0.96 0.67 198 (7.7)
W2 138 750 0.35 0.94 0.73 188 (15.7)
9. Historical diagnosis currently treated plus current diagnosis
(treated or untreated)
W1 123 1692 0.15 0.96 0.64 191 (7.4)
W2 115 764 0.29 0.96 0.76 151 (12.6)
10. Historical diagnosis currently treated plus current diagnosis
or symptom (treated or untreated)
W1 127 1691 0.16 0.96 0.65 196 (7.6)
W2 126 756 0.32 0.95 0.74 170 (14.2)
11. Historical or current diagnosis or symptom currently treated
plus current diagnosis untreated
W1 133 1688 0.16 0.96 0.65 205 (7.9)
W2 140 749 0.35 0.94 0.73 191 (16.0)
12. Historical or current diagnosis or symptom currently treated
plus current diagnosis or symptom untreated
W1 135 1688 0.17 0.96 0.65 207 (8.0)
W2 143 748 0.36 0.94 0.73 195 (16.3)
aNumber identified with CMD using MHI-5 data at Wave 1 = 824, at Wave 2 = 395
bNumber identified as not having CMD at Wave 1 = 1760, at Wave 2 = 800
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has remained stable over time while the incidence of
symptoms has increased. We therefore included symp-
tom codes in our analysis.
We found that using algorithm 9 (a historical diagno-
sis currently treated plus a current diagnosis whether
treated or untreated) at wave 2 resulted in a specificity
of 0.96, sensitivity 0.29 and PPV 0.76. This method
improves sensitivity considerably from using current
diagnosis alone, as is done in many studies using routine
data, whilst specificity remains high. It had the optimal
combination of specificity and PPV.
All false positive cases had historical diagnoses and
were currently treated. These may be cases that were
benefiting from their treatment and were asymptomatic
at the time of survey. False negatives, i.e. those identified
in the survey as having anxiety and depression but not
identified in primary care, were mainly those with
historical diagnoses of pain (71 %) or who had chronic
co-morbidities (50 %). Approximately 9 % of false nega-
tives had current symptom codes and 14 % had CMD
other than depression and anxiety recorded in primary
care. The latter is a limitation of using the MHI-scale in
its assessment of mental health status.
The MHI-5 scale asks questions relating to current
status (previous four weeks) and therefore current
symptoms will play an important role in questionnaire
completion. Additionally there appears to be an increas-
ing preference over time for recording symptoms over
diagnoses in primary care [18, 19]. Adding current
symptom codes to the algorithm improved sensitivity
(0.32) with a marginal effect on specificity (0.95) and
PPV (0.74). This algorithm (algorithm 10) produces a
sample size for analysis that is over five times that where
current diagnosis (algorithm 2) alone is used to identify
cases (Table 2).
Strengths and limitations
The assessment of CMD using MHI-5 has been made
previously [31, 36], although not through data linkage.
However the gold standard for identifying cases would
be to use the Clinical Interview Schedule-Revised [46].
A strength of this study is the analysis of large popula-
tion level data giving large sample sizes for calculating
the incidence of recorded anxiety and depression. The
use of routinely available data minimises the costs of
epidemiological research. The linkage of survey data to
SAIL data allowed for the validation of Read codes and
the use of these Read codes and algorithms in further
epidemiological research [47].
Response bias is a potential issue in the CHSNS. The
response rate to the first wave of the CHSNS is com-
parable to many population surveys, but the wave 2 re-
sponse was lower at 50.2 %. Selection bias is a potential
issue in using the GPD. The GPD population studied is
large but covers 168 out of 474 practices in Wales and
38.5 % (wave 1 period)/44.8 % (wave 2 period) of the
population aged 18–74 years. Those practices that are
not currently signed up to SAIL may be in some way
different to those that are. This may introduce bias in
the estimation of prevalence. However, it is unlikely
that the relationship between GP-recorded CMD and
CMD measured using the MHI-5 would be different
among practices in SAIL and not in SAIL. As such our
estimates of the relative performance of the different
algorithms are unlikely to have been affected. The
sensitivity of our case definitions is higher in wave 2
than wave 1 since more historical data are available and
also, possibly, because of the increase in the number of
prescriptions issued for antidepressants, anxiolytics and
hypnotics over the last decade [18].
A further strength of this study is the inclusion of symp-
tom codes. A recent study [48] found that CMD and sub
threshold psychiatric symptoms were both independently
associated with new-onset functional disability and signifi-
cant days lost from work. They suggest leaving symptoms
unaccounted for in surveys may lead to gross underesti-
mation of disability related to psychiatric morbidity.
Given the changing patterns of coding behaviour by
GPs and the constantly evolving Read code system, as-
sessment of prevalence based on these data alone would
be flawed. Analysis of GP utilisation data extrapolates an
estimate of community demand and need based upon
existing utilisation experience. It says more about mental
health resources, practice priorities, help-seeking behav-
iour and service capacity than about the real prevalence
or need in the population. Because we have been able to
externally validate these codes using the MHI-5, they
can be used as a platform for epidemiological research
into the CMD anxiety and depression and as an
outcome measure using routinely available GP data for
various studies including electronically linking partici-
pants in trials and traditional cohorts.
For epidemiological research, using large computerised
databases of routinely collected medical records, robust
findings rely on validation of methods for case ascertain-
ment. The method of identifying a case of anxiety and
depression from routinely collected primary care data,
the trade-off between sensitivity and specificity and
hence the choice of algorithm, will vary with study de-
sign. High specificity and therefore PPV, if necessary at
the expense of low sensitivity, is more crucial for validity
Table 3 False positives and false negatives for Algorithm 9
MHI-5 CMD case MHI-5 no CMD Totals
GPD case 115 36 151
GPD no CMD 280 764 1044
Totals 395 800 1195
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in creating primary care e-cohorts so that most cases
identified have the disorder of interest. This is particularly
important for case control studies, a common design in e-
studies where identification of large numbers of controls
is facilitated. Where the ratio of controls to cases is high,
misclassification of cases as controls, i.e. a high false
negative rate, may not bias results significantly. However,
misclassifying controls as cases has the potential for bias.
In such studies high PPVs and specificity are important.
We have explored how different combinations of codes
and algorithms affect these measures allowing for a more
robust understanding when using routine data. For
example using the algorithm based on current diagnosis
alone is highly specific and comparable with current litera-
ture. However the sensitivity is low and the sample size in
this study would be small.
Comparison with previous literature
The prevalence of the CMDs of anxiety and depression
found in this study is in keeping with other studies [4, 6, 9].
Changes in primary care recording of anxiety and depres-
sion in Wales mirror those found in other large primary
care datasets, [18, 19] and justify the inclusion of symptom
codes in our analysis rather than reflecting a true decrease
in the incidence of the diagnosis of anxiety and depression.
Strategies adopted in the Quality and Outcomes framework
for those with diagnosed depression may be having unin-
tended consequences on coding patterns possibly resulting
in a disincentive to record diagnoses [49].
Based on an MHI-5 cut point of ≤60, GPs diagnosed
around 30 % of participants defined as a case of CMD
by the MHI-5 score as having anxiety or depression
(diagnosis or symptom). This is similar to findings in the
Dutch population [39]. Several explanations exist why
those with probable CMD do not seek healthcare or, if
they do, why the general practitioner does not diagnose
them. These include stigma, spontaneous resolution
and patients presenting with physical symptoms/prob-
lems [47].
What this study adds
We have developed an algorithm with excellent specificity
and high PPV for detecting CMD (anxiety and depression)
with a trade off of low but expected sensitivity from rou-
tinely collected electronic primary care data for research
purposes. The Read code (diagnosis, symptoms and treat-
ment) lists plus the developed algorithms will be applicable
to other primary care datasets of routinely collected data,
thus creating a platform for future e-cohort research into
these conditions. We have demonstrated that using diagno-
sis and current treatment alone to identify cases for depres-
sion and anxiety using routinely collected primary care
data will miss a number of true cases given changes in GP
recording behaviour. We have also shown that the algo-
rithms are enhanced by the inclusion of current symptoms.
Implications
De-identified databanks of routinely collected clinical data
such as SAIL, CPRD (Clinical Practice Research Database)
[50] and THIN (The Health Improvement Network) [51]
[provide a rich resource for research. The development of
algorithms from complex datasets that identify cases with
high PPV is an important step in epidemiological research.
This work has implications for future research on the
common mental disorders anxiety and depression, and on
antidepressants. By understanding the performance of the
different algorithms we gain a lot of insight into their po-
tential use for research. We are now including the CMD
as mental health outcomes in studies across a range of
areas, including the environment, housing, suicide and for
clinical research [47, 52–54]. We plan to externally valid-
ate the algorithms developed to assess CMD in children
and young people using age-appropriate survey data.
Conclusions
The assessment of cases of CMD (anxiety and depression)
based on those with a historical diagnosis currently treated
plus a current diagnosis or symptom treated or untreated
(algorithm 10) will be useful as a platform for future
research in e-cohort studies using routinely collected pri-
mary care data. Assessing diagnosis only, in addition,
would allow comparison with other literature.
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